8-K: DNA X, Inc. Replaces RSUs with Cash Awards
Current Report (8-K)
DNA X, Inc. has replaced restricted stock units with cash awards for board members due to share unavailability.
Summary
- DNA X, Inc. announced on August 21, 2026, that its compensation committee approved a change in how board members are compensated.
- Instead of granting Restricted Stock Units (RSUs), all board members, including the CEO, will receive a cash award.
- This change is due to the unavailability of common stock shares under the company's 2019 Equity Incentive Plan.
- The cash award is designed to mirror the value and vesting schedule of RSUs, with a target value of $60,000 based on the stock price on August 21, 2026.
- These 'Phantom RSUs' will vest upon the earlier of the 2027 annual meeting or a change in control of the company.
- The cash payout will be equivalent to the fair market value of the underlying shares at the time of the vesting event.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive development, indicating a practical solution to an administrative issue regarding equity grants.
Positives
- Ensures continued equity-based compensation for board members despite share availability issues.
- The cash award structure is designed to closely replicate the intended value and vesting of RSUs, maintaining alignment with company performance.
- Provides clarity on compensation for board members through a defined methodology.
Negatives
- Indicates a potential limitation in the company's equity pool under the 2019 Equity Incentive Plan.
- The value of the cash award is subject to future stock price fluctuations at the time of vesting, introducing some uncertainty compared to a fixed RSU grant at the time of award.
Risks
- The unavailability of shares under the EIP could signal future constraints on employee stock options or other equity-based compensation, potentially impacting talent acquisition and retention.
- Future stock price volatility at the vesting event could result in a payout that is significantly higher or lower than anticipated at the time of the award.
Future Outlook
The future outlook for compensation structure indicates a reliance on cash awards in lieu of RSUs until the issue with share availability under the EIP is resolved. The value of these awards is tied to future stock performance at the time of vesting.
Management Comments
- The compensation committee approved the grant of a cash award to all members of the Board, including Mike Mulica, the Company's Chief Executive Officer, in lieu of a grant of restricted stock units (RSUs) under the Company's 2019 Equity Incentive Plan due to the unavailability of shares of common stock under the EIP.
- The amount of the Substitute Cash Grant will be determined using a methodology designed to closely replicate RSU vesting.
Industry Context
StockSavvy.ai notes that replacing RSUs with cash awards due to share unavailability is a pragmatic, albeit temporary, solution. Many growth-oriented tech companies face similar challenges with equity dilution and managing their stock option pools as they scale.
Stakeholder Impact
- Shareholders: The change may have a minor impact on share dilution if the company eventually needs to issue more shares to replenish the EIP. The cash award structure aims to maintain board alignment with shareholder value.
- Board Members/Officers: Continue to receive compensation tied to company performance and vesting events, albeit in a different form.
- Employees: May face uncertainty regarding future equity compensation if the EIP's share availability issues persist.
Next Steps
- The company will continue to grant cash awards to board members in lieu of RSUs until shares are available under the EIP.
- The cash awards will vest upon the earlier of the company's 2027 annual meeting of stockholders or a change in control.
- The cash payout will be made as of the Vesting Event.
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Date of Compensation Committee meeting and approval of Substitute Cash Grant; Fair market value of common stock used for Phantom RSUs. |
| 2027-01-01 | Potential vesting date for Substitute Cash Grant (earlier of 2027 annual meeting or change in control). |
| 2026-08-27 | Date of filing the Form 8-K. |
Keywords
equity compensation, cash award, restricted stock units, board compensation, equity incentive plan, change in control, stock vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.